H.C. Wainwright maintains Biohaven stock at Neutral after MDD trial failure

1 hour ago 4
Read Entire Article
  1. Homepage
  2. Finance
  3. H.C. Wainwright maintains Biohaven stock at Neutral after MDD trial failure

Related

YY Group reports 33.7% revenue growth in first half 2025

YY Group reports 33.7% revenue growth in first half 2025

59 minutes ago 0
374Water partners with Cedar Rapids to destroy PFAS in biosolids

374Water partners with Cedar Rapids to destroy PFAS in bioso...

59 minutes ago 0
Medicare withdraws skin substitute coverage changes set for 2026

Medicare withdraws skin substitute coverage changes set for ...

59 minutes ago 0

Trending

1. jadan baugh
2. aapl stock
3. charles schwab
4. qbts stock
5. ionq stock
6. tsla stock
7. tre wisner
8. oxford utd vs southampton
9. somaliland
10. barnes and noble

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

11 months ago 647
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

9 months ago 513
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

9 months ago 378
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

9 months ago 336
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

11 months ago 331
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved